Delivery Order SPE2DB22D3501-SPE2DB24FWK98

Award Date 7/29/24
Potential Completion Date 8/19/24
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $26,525.70 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMFINZI 500 MG/10 ML VIAL 10ML. The contract has an ultimate completion date of July 24, 2025. The contract is not a set-aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,262.85, is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a completion date of July 14, 2025. The contract is a Firm Fixed Price agreement and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The award has a ceiling value of $31,830.84 and a completion date of May 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 MG/10 ML VIAL 10ML pharmaceutical products. The $20,560.00 firm-fixed-price contract has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a $31,830.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a period of performance through February 5, 2025. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, with a ceiling value of $31,830.84 and a period of performance ending on June 10, 2025. The contract is not set aside for any small business designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,535,133 units of IMFINZI 500 MG/10 ML VIAL 10ML. The contract has a completion date of February 26, 2024 and a potential value of $15,420.00. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $53,051.40 and a performance period through July 25, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the delivery of IMFINZI 500 MG/10 ML vials. The order has a potential value of $5,140.00 and a completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, and it appears the company also holds an indefinite delivery contract (IDC) with DLA valued at up to...
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a ceiling value of $23,873.13 and is a firm fixed-price delivery order that does not utilize any set-aside designation. The contract has an ultimate completion date of May 29, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWK98
    Delivery Order

This is a $7,710 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of IMFINZI 500 MG/10 ML vials, a pharmaceutical product. The order has an ultimate completion date of August 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of medical commodities, including prescription drugs and supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/28/24, 9:49 AM